Research Paper Volume 16, Issue 3 pp 2679—2701
Underlying mechanisms of novel cuproptosis-related dihydrolipoamide branched-chain transacylase E2 (DBT) signature in sunitinib-resistant clear-cell renal cell carcinoma
Figure 3. Heatmap displaying the differential expression of CRGs expression in progression of ccRCC. (A) Heatmap displaying the differential expression of CRGs in normal tissues in TCGA-KIRC cohort (n = 602). (B) Expression of CRGs in normal tissues and tumors samples from the TCGA-KIRC cohort by (C) stage, (D) Tumor, (E) Node, and (F) Metastasis.